Airflow limitation, lung volumes and systemic inflammation in a general population
暂无分享,去创建一个
H Völzke | H Schulz | H. Völzke | C. Vogelmeier | S. Gläser | B. Koch | H. Schulz | T. Ittermann | H. Wallaschofski | M. Nauck | S. Felix | R. Ewert | C Vogelmeier | R Ewert | M Nauck | B Koch | C Schäper | T Ittermann | S Gläser | H Wallaschofski | C Warnke | S B Felix | C. Warnke | C. Schäper | C. Vogelmeier | R. Ewert | Henry Völzke | Henri Wallaschofski | H. Völzke | H. Wallaschofski
[1] J E Cotes,et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[2] H. Völzke,et al. [Reference values for lung function testing in adults--results from the study of health in Pomerania" (SHIP)]. , 2009, Deutsche medizinische Wochenschrift.
[3] M. Kenward,et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.
[4] J. Roca,et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[5] S. Cummings,et al. The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women. , 2003, The American journal of medicine.
[6] C. Lewis,et al. Plasma fibrinogen and lung function: the CARDIA Study. , 2006, International journal of epidemiology.
[7] K. Schultz,et al. [Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin]. , 2007, Pneumologie.
[8] T H Beaty,et al. Impaired pulmonary function as a risk factor for mortality. , 1982, American journal of epidemiology.
[9] R. Poulton,et al. Systemic inflammation and lung function in young adults , 2007, Thorax.
[10] W. Rathmann,et al. Cohort profile: the study of health in Pomerania. , 2011, International journal of epidemiology.
[11] J. Barberà,et al. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. , 2009, Journal of applied physiology.
[12] S. Rubin,et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects , 2005, Thorax.
[13] P. Elliott,et al. Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.
[14] Dan Xu,et al. Role of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary hypertension in hamsters , 2010, Respiratory research.
[15] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[16] R M Gardner,et al. Performance evaluation of contemporary spirometers. , 1990, Chest.
[17] M. Cosio,et al. Detection of expiratory flow limitation during exercise in COPD patients. , 1997, Journal of applied physiology.
[18] Buist As. Standardization of spirometry. , 1987 .
[19] K. Nakashima,et al. [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[20] Standardization of spirometry--1987 update. Official statement of American Thoracic Society. , 1987, Respiratory care.
[21] H. Völzke,et al. Lung function reference values in different German populations. , 2011, Respiratory medicine.
[22] A. Clauss,et al. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .
[23] Konrad Schultz,et al. Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD) , 2007 .
[24] Henry Völzke,et al. Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. , 2010, Journal of psychiatric research.
[25] H. Boshuizen,et al. Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.
[26] Organización Mundial de la Salud. Guidelines for ATC classification and DDD assignment , 1996 .
[27] Inês Barroso,et al. Genome-wide association study identifies five loci associated with lung function , 2010, Nature Genetics.
[28] Albert Hofman,et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. , 2004, European heart journal.
[29] J. Roca,et al. Standardization of the measurement of transfer factor (diffusing capacity) , 1993, European Respiratory Journal.
[30] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[31] G. Viegi,et al. Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.
[32] H. Magnussen,et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. , 2009, Chest.
[33] A. Clauss. [Rapid physiological coagulation method in determination of fibrinogen]. , 1957, Acta haematologica.
[34] A. Eggen,et al. Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromsø Study 2001. , 2007, Respiratory medicine.
[35] P. Schnohr,et al. Spirometric findings and mortality in never-smokers. , 1990, Journal of clinical epidemiology.
[36] K. Godfrey,et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. , 1991, BMJ.
[37] M. Noppen,et al. Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD. , 1998, American journal of respiratory and critical care medicine.
[38] P. O'Byrne,et al. Is nedocromil sodium effective treatment for asthma? , 1993, The European respiratory journal.
[39] A. Buist,et al. Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. , 2009, Respiratory medicine.
[40] Referenzwerte für die Spirometrie bei Erwachsenen Ergebnisse der „Study of Health in Pomerania (SHIP) , 2009 .
[41] J. Hankinson,et al. Interpretative strategies for lung function tests , 2005, European Respiratory Journal.
[42] F. Rasmussen,et al. High-sensitive C-reactive protein is associated with reduced lung function in young adults , 2008, European Respiratory Journal.
[43] G. Watt,et al. Inverse Association Between Birth Weight and C-Reactive Protein Concentrations in the MIDSPAN Family Study , 2004, Arteriosclerosis, Thrombosis and Vascular Biology.
[44] W. Markiewicz,et al. Factor analysis of risk variables associated with low-grade inflammation. , 2008, Atherosclerosis.
[45] Patrick Royston,et al. Multivariable Model-Building: A Pragmatic Approach to Regression Analysis based on Fractional Polynomials for Modelling Continuous Variables , 2008 .
[46] J. Hankinson,et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.
[47] J. E. Hansen,et al. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. , 2007, Chest.